Piro Anna, Tagarelli Antonio, Tagarelli Giuseppe, Lagonia Paolo, Quattrone Aldo
Istituto di Scienze Neurologiche-CNR, Mangone, Cosenza, Italy.
Int Rev Immunol. 2008 Jan-Apr;27(1-2):1-17. doi: 10.1080/08830180701848995.
We wish to commemorate Paul Ehrlich on the centennial of his being awarded the Nobel Prize in Physiology or Medicine in 1908. His studies are now considered as milestones in immunology: the morphology of leukocytes; his side-chain theory where he defined the cellular receptor for first time; and his clarification of the difference between serum therapy and chemotherapy. Ehrlich also invented the first chemotherapeutic drug: compound 606, or Salvarsan. We have used some original documents from the Royal Society of London, where Ehrlich was a fellow, and from Leipzig University, where he took a degree in medicine.
我们希望纪念保罗·埃尔利希(Paul Ehrlich),2008年是他荣获诺贝尔生理学或医学奖一百周年。他的研究如今被视为免疫学的里程碑:白细胞的形态学;他首次定义细胞受体的侧链理论;以及他对血清疗法和化学疗法差异的阐明。埃尔利希还发明了第一种化疗药物:606化合物,即洒尔佛散。我们使用了来自伦敦皇家学会(埃尔利希是该学会会员)以及莱比锡大学(他在该校获得医学学位)的一些原始文献。